Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study

Saved in:

Bibliographic Details
Published in:	Thrombosis research Vol. 112; no. 1; pp. 59 - 64
Main Authors:	Jurasz, Paul, North, Scott, Venner, Peter, Radomski, Marek W
Format:	Journal Article
Language:	English
Published:	New York, NY Elsevier Ltd 2003 Elsevier Science
Subjects:	Aged Aggregometry Biological and medical sciences Biomarkers, Tumor - blood Blood and lymphatic vessels Blood Platelets - metabolism Cancer Cardiology. Vascular system Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Humans Male Matrix Metalloproteinase 2 - blood Matrix Metalloproteinase 2 - metabolism Matrix metalloproteinases Medical sciences Middle Aged Neoplasm Metastasis Platelet Activation Platelets Prostatic Neoplasms - blood Prostatic Neoplasms - enzymology Risk Assessment - methods PAR Matrix metalloproteinases VEGF PLC GP MAPK Aggregometry MMP LHRH TCIPA PI3K Platelets Cancer Human Urinary system disease Prostate disease Enzyme Metalloendopeptidases Cardiovascular disease Metastasis Malignant tumor Gelatinase A Peptidases Platelet Hydrolases Male genital diseases Prostate cancer
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23
ISSN:	0049-3848 1879-2472
DOI:	10.1016/j.thromres.2003.10.012